141 related articles for article (PubMed ID: 30533477)
1. High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer.
Kitson SJ; Lindsay J; Sivalingam VN; Rutter MK; Crosbie EJ
Gynecol Oncol Rep; 2018 Nov; 26():109-110. PubMed ID: 30533477
[No Abstract] [Full Text] [Related]
2. Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.
Resnick K; Straughn JM; Backes F; Hampel H; Matthews KS; Cohn DE
Obstet Gynecol; 2009 Sep; 114(3):530-536. PubMed ID: 19701031
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database.
Trabert B; Wentzensen N; Felix AS; Yang HP; Sherman ME; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):261-7. PubMed ID: 25587111
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South Korea.
Jo H; Kim SI; Wang W; Seol A; Han Y; Kim J; Park IS; Lee J; Yoo J; Han KD; Song YS
Front Oncol; 2022; 12():872995. PubMed ID: 35785211
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism.
Holm NS; Glintborg D; Andersen MS; Schledermann D; Ravn P
Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1173-6. PubMed ID: 22583042
[TBL] [Abstract][Full Text] [Related]
6. The Influence of the Metabolic Syndrome on Early Postoperative Outcomes of Patients With Advanced-stage Endometrial Cancer.
Bacalbasa N; Diaconu C; Iliescu L; Savu C; Savu C; Balalau C; Dimitriu M; Filipescu A; Bratu OG; Neacsu A; Cretoiu D; Halmaciu I; Balescu I
In Vivo; 2020; 34(5):2913-2917. PubMed ID: 32871832
[TBL] [Abstract][Full Text] [Related]
7. The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study.
Kitson SJ; Lindsay J; Sivalingam VN; Lunt M; Ryan NAJ; Edmondson RJ; Rutter MK; Crosbie EJ
Gynecol Oncol; 2018 Jan; 148(1):154-160. PubMed ID: 29174567
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.
Ryan NAJ; Blake D; Cabrera-Dandy M; Glaire MA; Evans DG; Crosbie EJ
Syst Rev; 2018 Aug; 7(1):121. PubMed ID: 30115102
[TBL] [Abstract][Full Text] [Related]
10. Prospective cohort study of metabolic syndrome and endometrial cancer survival.
Kokts-Porietis RL; McNeil J; Nelson G; Courneya KS; Cook LS; Friedenreich CM
Gynecol Oncol; 2020 Sep; 158(3):727-733. PubMed ID: 32600790
[TBL] [Abstract][Full Text] [Related]
11. A single centre experience of metabolic syndrome and endometrial carcinoma: 5 years review.
Shafiee MN; Razak N; Ahmad MF; Abd Aziz N; Adeeb N
J Obstet Gynaecol; 2021 Feb; 41(2):285-289. PubMed ID: 33258710
[TBL] [Abstract][Full Text] [Related]
12. Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer.
Friedenreich CM; Biel RK; Lau DC; Csizmadi I; Courneya KS; Magliocco AM; Yasui Y; Cook LS
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2384-95. PubMed ID: 21921255
[TBL] [Abstract][Full Text] [Related]
13. Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women.
Park B
J Gynecol Oncol; 2022 Jul; 33(4):e35. PubMed ID: 35320886
[TBL] [Abstract][Full Text] [Related]
14. Postoperative pain medication requirements in patients undergoing computer-assisted (“Robotic”) and standard laparoscopic procedures for newly diagnosed endometrial cancer.
Leitao MM; Malhotra V; Briscoe G; Suidan R; Dholakiya P; Santos K; Jewell EL; Brown CL; Sonoda Y; Abu-Rustum NR; Barakat RR; Gardner GJ
Ann Surg Oncol; 2013 Oct; 20(11):3561-7. PubMed ID: 23797751
[TBL] [Abstract][Full Text] [Related]
15. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
16. Lynch syndrome associated endometrial carcinomas in Western Australia: an analysis of universal screening by mismatch repair protein immunohistochemistry.
Gupta S; Nichols CB; Phillips J; O'Sullivan S; Ayres C; Mohan GR; Leung Y; Stewart CJR; Tan A; Schofield L; Salfinger SG; Kiraly-Borri C; Pachter N; Cohen PA
Int J Gynecol Cancer; 2021 Jun; 31(6):846-851. PubMed ID: 33858951
[TBL] [Abstract][Full Text] [Related]
17. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
18. Relation of metabolic syndrome with endometrial pathologies in patients with abnormal uterine bleeding.
Özdemir S; Batmaz G; Ates S; Celik C; Incesu F; Peru C
Gynecol Endocrinol; 2015; 31(9):725-9. PubMed ID: 26182187
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends.
Waldmann A; Eisemann N; Katalinic A
Geburtshilfe Frauenheilkd; 2013 Feb; 73(2):123-129. PubMed ID: 24771908
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and endometrial carcinoma.
Bjørge T; Stocks T; Lukanova A; Tretli S; Selmer R; Manjer J; Rapp K; Ulmer H; Almquist M; Concin H; Hallmans G; Jonsson H; Stattin P; Engeland A
Am J Epidemiol; 2010 Apr; 171(8):892-902. PubMed ID: 20219764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
